Betaine for Health & Longevity - Quick Reference Sheet

Betaine for Health & Longevity

Created on 06/16/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Betaine, an inexpensive, well-tolerated compound from foods like beets and spinach, most reliably lowers elevated homocysteine, a blood marker tied to heart and brain health. It may modestly boost muscular strength and support liver fat handling. Higher doses raise cholesterol, the main trade-off. Brain and longevity claims rest on biology, not human trials. (Full Review)

Protocol

Standard General-Health Dose
1–3 g/day
Anhydrous (TMG) for homocysteine and methylation support; stays below the cholesterol-raising threshold.
Homocysteine-Focused Dosing
1.5–6 g/day
Clear dose-response; lower end (1.5–3 g/day) balances efficacy against the lipid trade-off at ≥4 g/day.
Performance/Strength Dosing
~2.5 g/day
Often split into two doses, for at least 7 days and usually several weeks.
Time to effect
Homocysteine Reduction
~6 weeks
Measurable within about 6 weeks of consistent use.
Muscular Strength
≥7 days
Benefits appear after at least 7 days and accrue over several weeks of training.

Benefits

Contraindications
  • Established high LDL cholesterol or cardiovascular disease (caution at higher doses)
  • Significant kidney or liver impairment
  • FMO3-related trimethylaminuria
  • Pregnant or breastfeeding women
  • Inherited methylation disorder using high doses without medical supervision
Key Interactions
  • Homocysteine-lowering nutrients (folate, vitamin B6, vitamin B12)
  • Methyl-consuming supplements (niacin, NMN, nicotinamide riboside)
  • Lipid-lowering therapy (statins such as atorvastatin, rosuvastatin; ezetimibe)
  • Choline and TMG-containing products
  • Betaine hydrochloride (over-the-counter, for stomach acid; not to be confused with anhydrous)

Risk & Side Effects

  • High: Increased total and LDL cholesterol
  • Medium: Gastrointestinal discomfort
  • Low: "Fishy" body odor; elevated methionine
  • Speculative: Trimethylamine N-oxide (TMAO) and cardiovascular concern

Monitoring

Marker Target Why
Homocysteine ~6–8 µmol/L Primary efficacy marker for betaine
Total cholesterol <200 mg/dL Detects the main dose-dependent downside
LDL cholesterol <100 mg/dL (lower if high cardiovascular risk) Tracks the lipid trade-off
Methionine Within lab reference range Safety marker at high doses
Vitamin B12 and folate Mid-to-upper reference range Context for the parallel methylation pathway

Cadence: Baseline, then re-check at ~8–12 weeks after starting or any dose increase, then every 6–12 months during continued use.

Qualitative Assessment

  • Subjective strength and training performance (e.g., progression in key lifts)
  • Any gastrointestinal discomfort (nausea, bloating, diarrhea) signaling a need to split or lower the dose
  • Presence of any fishy body odor, which suggests reducing the dose
  • General energy and well-being, recognizing these are non-specific